New Delhi, Jan. 27 -- Indian Pharmaceutical Alliance on Tuesday welcomed the conclusion of the India-EU Free Trade Agreement, calling it an important milestone in strengthening bilateral trade. Secretary General, Indian Pharmaceutical Alliance, Sudarshan Jain said that the expected removal of EU tariffs of up to 11 per cent on pharmaceuticals will enhance trade and support greater access to innovative medicines for Indian patients.

Sudarshan Jain said, "IPA welcomes the conclusion of the India-EU Free Trade Agreement, which marks an important milestone in strengthening bilateral trade. India and the European Union are long-standing and trusted partners in the pharmaceutical sector. Indian companies play a critical role in supplying quali...